Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia

Acute myelogenous leukemia (AML) is a heterogeneous disease and often relapses after standard chemotherapy. Recently, the neddylation (NEDD8) and the mammalian target of rapamycin (mTOR) signaling pathways have emerged as promising pharmaceutical targets for AML therapy. However, the interaction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Naxin, Azadniv, Mitra, Coppage, Myra, Nemer, Mary, Mendler, Jason, Becker, Michael, Liesveld, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348338/
https://www.ncbi.nlm.nih.gov/pubmed/30699367
http://dx.doi.org/10.1016/j.tranon.2019.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348338/
https://www.ncbi.nlm.nih.gov/pubmed/30699367
http://dx.doi.org/10.1016/j.tranon.2019.01.001

Ejemplares similares